Log In
BCIQ
Print this Print this
 

GA Depot

  Manage Alerts
Collapse Summary General Information
Company Mapi-Pharma Ltd.
DescriptionLong-acting depot formulation of glatiramer acetate, a selective major histocompatibility complex class II (MHCII) modulator
Molecular Target Major histocompatibility complex class II (MHCII)
Mechanism of Action 
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPhase II
Standard IndicationMultiple sclerosis (MS)
Indication DetailsTreat relapsing-remitting multiple sclerosis (RRMS)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today